Brief: Cannara Biotech Posts Q2 Net Revenue Of $13 Mln
April 24 (Reuters) - Lovesac Co LOVE.O :
* CANNARA BIOTECH INC. REPORTS Q2 2023 FINANCIAL RESULTS
WITH
QUARTERLY NET REVENUES OF $13 MILLION, A 76% INCREASE COMPARED
TO Q2 2022
* CANNARA BIOTECH INC - Q2 2023 NET REVENUE OF $13 MILLION
* CANNARA BIOTECH INC - COMPANY HAS $25.6 MILLION IN WORKING
CAPITAL AS OF FEBRUARY 28, 2023, WHICH INCLUDES $4.1 MILLION OF
CASH ON HAND
Source text for Eikon: ID:nCNW6f7PVa
Further company coverage: LOVE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lovesac Co
See all newsLovesac Q1 sales flat but slightly beat estimates
U.S. STOCKS ON THE MOVE -Adobe, Salesforce, Stryker
U.S. STOCKS ON THE MOVE -Firefly Neuroscience, Liberty Energy, ImmunityBio
U.S. STOCKS ON THE MOVE-Corebridge, Robinhood, Navan
Brief: The Lovesac Company Expands Share Repurchase Authorization By $40 Million